272 related articles for article (PubMed ID: 33597261)
1. Analysis of recurrently protected genomic regions in cell-free DNA found in urine.
Markus H; Zhao J; Contente-Cuomo T; Stephens MD; Raupach E; Odenheimer-Bergman A; Connor S; McDonald BR; Moore B; Hutchins E; McGilvrey M; de la Maza MC; Van Keuren-Jensen K; Pirrotte P; Goel A; Becerra C; Von Hoff DD; Celinski SA; Hingorani P; Murtaza M
Sci Transl Med; 2021 Feb; 13(581):. PubMed ID: 33597261
[TBL] [Abstract][Full Text] [Related]
2. Real-time analysis of the cancer genome and fragmentome from plasma and urine cell-free DNA using nanopore sequencing.
van der Pol Y; Tantyo NA; Evander N; Hentschel AE; Wever BM; Ramaker J; Bootsma S; Fransen MF; Lenos KJ; Vermeulen L; Schneiders FL; Bahce I; Nieuwenhuijzen JA; Steenbergen RD; Pegtel DM; Moldovan N; Mouliere F
EMBO Mol Med; 2023 Dec; 15(12):e17282. PubMed ID: 37942753
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide analysis of aberrant position and sequence of plasma DNA fragment ends in patients with cancer.
Budhraja KK; McDonald BR; Stephens MD; Contente-Cuomo T; Markus H; Farooq M; Favaro PF; Connor S; Byron SA; Egan JB; Ernst B; McDaniel TK; Sekulic A; Tran NL; Prados MD; Borad MJ; Berens ME; Pockaj BA; LoRusso PM; Bryce A; Trent JM; Murtaza M
Sci Transl Med; 2023 Jan; 15(678):eabm6863. PubMed ID: 36630480
[TBL] [Abstract][Full Text] [Related]
4. Characterizing the molecular composition and diagnostic potential of Mycobacterium tuberculosis urinary cell-free DNA using next-generation sequencing.
Oreskovic A; Waalkes A; Holmes EA; Rosenthal CA; Wilson DPK; Shapiro AE; Drain PK; Lutz BR; Salipante SJ
Int J Infect Dis; 2021 Nov; 112():330-337. PubMed ID: 34562627
[TBL] [Abstract][Full Text] [Related]
5. Altered cfDNA fragmentation profile in hypomethylated regions as diagnostic markers in breast cancer.
Wang J; Niu Y; Yang M; Shu L; Wang H; Wu X; He Y; Chen P; Zhong G; Tang Z; Zhang S; Guo Q; Wang Y; Yu L; Gou D
Epigenetics Chromatin; 2023 Sep; 16(1):33. PubMed ID: 37740218
[TBL] [Abstract][Full Text] [Related]
6. Characteristics, origin, and potential for cancer diagnostics of ultrashort plasma cell-free DNA.
Hudecova I; Smith CG; Hänsel-Hertsch R; Chilamakuri CS; Morris JA; Vijayaraghavan A; Heider K; Chandrananda D; Cooper WN; Gale D; Garcia-Corbacho J; Pacey S; Baird RD; Rosenfeld N; Mouliere F
Genome Res; 2022 Feb; 32(2):215-227. PubMed ID: 34930798
[TBL] [Abstract][Full Text] [Related]
7. Fragmentation patterns and personalized sequencing of cell-free DNA in urine and plasma of glioma patients.
Mouliere F; Smith CG; Heider K; Su J; van der Pol Y; Thompson M; Morris J; Wan JCM; Chandrananda D; Hadfield J; Grzelak M; Hudecova I; Couturier DL; Cooper W; Zhao H; Gale D; Eldridge M; Watts C; Brindle K; Rosenfeld N; Mair R
EMBO Mol Med; 2021 Aug; 13(8):e12881. PubMed ID: 34291583
[TBL] [Abstract][Full Text] [Related]
8. Non-random fragmentation patterns in circulating cell-free DNA reflect epigenetic regulation.
Ivanov M; Baranova A; Butler T; Spellman P; Mileyko V
BMC Genomics; 2015; 16 Suppl 13(Suppl 13):S1. PubMed ID: 26693644
[TBL] [Abstract][Full Text] [Related]
9. Orientation-aware plasma cell-free DNA fragmentation analysis in open chromatin regions informs tissue of origin.
Sun K; Jiang P; Cheng SH; Cheng THT; Wong J; Wong VWS; Ng SSM; Ma BBY; Leung TY; Chan SL; Mok TSK; Lai PBS; Chan HLY; Sun H; Chan KCA; Chiu RWK; Lo YMD
Genome Res; 2019 Mar; 29(3):418-427. PubMed ID: 30808726
[TBL] [Abstract][Full Text] [Related]
10. The Effect of Preanalytical and Physiological Variables on Cell-Free DNA Fragmentation.
van der Pol Y; Moldovan N; Verkuijlen S; Ramaker J; Boers D; Onstenk W; de Rooij J; Bahce I; Pegtel DM; Mouliere F
Clin Chem; 2022 Jun; 68(6):803-813. PubMed ID: 35292813
[TBL] [Abstract][Full Text] [Related]
11. Genomewide bisulfite sequencing reveals the origin and time-dependent fragmentation of urinary cfDNA.
Cheng THT; Jiang P; Tam JCW; Sun X; Lee WS; Yu SCY; Teoh JYC; Chiu PKF; Ng CF; Chow KM; Szeto CC; Chan KCA; Chiu RWK; Lo YMD
Clin Biochem; 2017 Jun; 50(9):496-501. PubMed ID: 28238813
[TBL] [Abstract][Full Text] [Related]
12. Ultrasensitive hybridization capture: Reliable detection of <1 copy/mL short cell-free DNA from large-volume urine samples.
Oreskovic A; Lutz BR
PLoS One; 2021; 16(2):e0247851. PubMed ID: 33635932
[TBL] [Abstract][Full Text] [Related]
13. Cell-Free DNA Fragmentomics: The Novel Promising Biomarker.
Qi T; Pan M; Shi H; Wang L; Bai Y; Ge Q
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675018
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of TERT promoter mutations in urinary cell-free DNA and sediment DNA for detection of bladder cancer.
Stasik S; Salomo K; Heberling U; Froehner M; Sommer U; Baretton GB; Ehninger G; Wirth MP; Thiede C; Fuessel S
Clin Biochem; 2019 Feb; 64():60-63. PubMed ID: 30528938
[TBL] [Abstract][Full Text] [Related]
15. Fragment Size-Based Enrichment of Viral Sequences in Plasma Cell-Free DNA.
Phung Q; Lin MJ; Xie H; Greninger AL
J Mol Diagn; 2022 May; 24(5):476-484. PubMed ID: 35569878
[TBL] [Abstract][Full Text] [Related]
16. Multidimensional fragmentomic profiling of cell-free DNA released from patient-derived organoids.
Kim J; Hong SP; Lee S; Lee W; Lee D; Kim R; Park YJ; Moon S; Park K; Cha B; Kim JI
Hum Genomics; 2023 Oct; 17(1):96. PubMed ID: 37898819
[TBL] [Abstract][Full Text] [Related]
17. Fragment Ends of Circulating Microbial DNA as Signatures for Pathogen Detection in Sepsis.
Wang G; Lam WKJ; Ling L; Ma ML; Ramakrishnan S; Chan DCT; Lee WS; Cheng SH; Chan RWY; Yu SCY; Tse IOL; Wong WT; Jiang P; Chiu RWK; Allen Chan KC; Lo YMD
Clin Chem; 2023 Feb; 69(2):189-201. PubMed ID: 36576350
[TBL] [Abstract][Full Text] [Related]
18. Circulating nuclear DNA structural features, origins, and complete size profile revealed by fragmentomics.
Sanchez C; Roch B; Mazard T; Blache P; Dache ZAA; Pastor B; Pisareva E; Tanos R; Thierry AR
JCI Insight; 2021 Apr; 6(7):. PubMed ID: 33571170
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Single Molecule, Real-Time Sequencing and Nanopore Sequencing for Analysis of the Size, End-Motif, and Tissue-of-Origin of Long Cell-Free DNA in Plasma.
Yu SCY; Deng J; Qiao R; Cheng SH; Peng W; Lau SL; Choy LYL; Leung TY; Wong J; Wong VW; Wong GLH; Jiang P; Chiu RWK; Chan KCA; Lo YMD
Clin Chem; 2023 Feb; 69(2):168-179. PubMed ID: 36322427
[TBL] [Abstract][Full Text] [Related]
20. Cell-Free DNA Provides a Good Representation of the Tumor Genome Despite Its Biased Fragmentation Patterns.
Ma X; Zhu L; Wu X; Bao H; Wang X; Chang Z; Shao YW; Wang Z
PLoS One; 2017; 12(1):e0169231. PubMed ID: 28046008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
